CWM
ZOM

CarsonAllaria Wealth Management’s Zomedica Corp. ZOM Stock Holding History

CarsonAllaria Wealth Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20
Closed – – 389
2022
Q4 		$0 Buy
+20
New +$4 ﹤0.01% 375

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CarsonAllaria Wealth Management's ZOM Position: Q1 2023 in Review

CarsonAllaria Wealth Management sold out of Zomedica Corp. (ZOM) in Q1 2023, closing a stake of 20 shares.

CarsonAllaria Wealth Management first reported a position in ZOM in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 90 funds tracked by Wall St. Rank hold ZOM as of Q1 2023.

  • CarsonAllaria Wealth Management reported no remaining Zomedica Corp. position as of Q1 2023 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 20 Zomedica Corp. shares in Q1 2023.
  • CarsonAllaria Wealth Management first reported a position in Zomedica Corp. in Q4 2022 and held it in 1 quarter.
  • CarsonAllaria Wealth Management's Zomedica Corp. position peaked at $0 in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q1 2023, filed 26 Apr 2023.